Skip to main content

Lobbying activity

Who's lobbying Congress, for whom, and on what, from federal Lobbying Disclosure Act filings. Covers both chambers, synced daily. 273 filings

Top spenders & firms Spend by issue Political contributions Revolving door

  Showing filings that named HR 1262. Clear
Clear
Q2
ASTRAZENECA PHARMACEUTICALS LP for ASTRAZENECA PHARMACEUTICALS LP
2nd Quarter (Apr 1 - June 30) 2025 · Delaware · House · Senate
Health Issues, Medicare/Medicaid, Pharmacy, Taxation/Internal Revenue Code
View →
Q2
AVENUE SOLUTIONS for ALLIANCE FOR REGENERATIVE MEDICINE
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate · $50,000.00 income
Medicare/Medicaid
View →
Q2
ALSTON & BIRD LLP for ST. JUDE CHILDREN'S RESEARCH HOSPITAL
2nd Quarter (Apr 1 - June 30) 2025 · Tennessee · House · Senate · $10,000.00 income
Health Issues
View →
Q2
AKIN GUMP STRAUSS HAUER & FELD for BIOTECHNOLOGY INNOVATION ORGANIZATION
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate · $60,000.00 income
Health Issues, Medicare/Medicaid, Trade (domestic/foreign)
View →
Q2
MEHLMAN CONSULTING, INC. for ULTRAGENYX PHARMACEUTICAL, INC.
2nd Quarter (Apr 1 - June 30) 2025 · California · House · Senate · $60,000.00 income
Health Issues
View →
2T
SPARK THERAPEUTICS, INC. for SPARK THERAPEUTICS, INC.
2nd Quarter (Apr 1 - June 30) 2025 · Pennsylvania · House · Senate
Medicare/Medicaid, Health Issues
View →
Q2
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate
Budget/Appropriations, Copyright/Patent/Trademark, Health Issues, Medicare/Medicaid
View →
Q2
AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC. for AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate
Health Issues, Taxation/Internal Revenue Code, Tobacco, Budget/Appropriations
View →
Q2
DLA PIPER LLP (US) for BIOTECHNOLOGY INNOVATION ORGANIZATION
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate · $60,000.00 income
Medical/Disease Research/Clinical Labs, Health Issues, Medicare/Medicaid, Pharmacy
View →
Q2
INCYTE CORPORATION for INCYTE CORPORATION
2nd Quarter (Apr 1 - June 30) 2025 · Delaware · House · Senate
Medicare/Medicaid
View →
Q2
ACADIA PHARMACEUTICALS for ACADIA PHARMACEUTICALS
2nd Quarter (Apr 1 - June 30) 2025 · California · House · Senate
Taxation/Internal Revenue Code, Health Issues, Medicare/Medicaid
View →
Q2
PTC THERAPEUTICS, INC. for PTC THERAPEUTICS, INC.
2nd Quarter (Apr 1 - June 30) 2025 · New Jersey · House · Senate
Taxation/Internal Revenue Code, Health Issues, Medical/Disease Research/Clinical Labs, Medicare/Medicaid
View →
Q2
HARMONY BIOSCIENCES for HARMONY BIOSCIENCES
2nd Quarter (Apr 1 - June 30) 2025 · Pennsylvania · House · Senate
Pharmacy
View →
Q2
NOVARTIS for NOVARTIS
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate
Budget/Appropriations, Copyright/Patent/Trademark, Health Issues, Medicare/Medicaid
View →
Q2
ROBERTI GLOBAL (FKA ROBERTI WHITE, LLC) for BIOTECHNOLOGY INNOVATION ORGANIZATION (BIO)
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate · $60,000.00 income
Medicare/Medicaid, Health Issues
View →
Q2
TIBER CREEK GROUP for ACADIA PHARMACEUTICALS, INC.
2nd Quarter (Apr 1 - June 30) 2025 · California · House · Senate · $80,000.00 income
Health Issues, Taxation/Internal Revenue Code
View →
Q2
RARE DISEASE COMPANY COALITION for RARE DISEASE COMPANY COALITION
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate
Budget/Appropriations, Pharmacy, Science/Technology, Trade (domestic/foreign)
View →
Q2
ARNOLD & PORTER KAYE SCHOLER LLP for NEURELIS, INC.
2nd Quarter (Apr 1 - June 30) 2025 · California · House · Senate · $10,000.00 income
Health Issues
View →
Q2
TRAVERE THERAPEUTICS for TRAVERE THERAPEUTICS
2nd Quarter (Apr 1 - June 30) 2025 · California · House · Senate
Health Issues, Pharmacy, Medical/Disease Research/Clinical Labs, Medicare/Medicaid
View →
Q2
BRIDGEBIO PHARMA, INC. for BRIDGEBIO PHARMA, INC.
2nd Quarter (Apr 1 - June 30) 2025 · California · House · Senate
Pharmacy
View →
Q2
ASSOCIATION FOR CLINICAL ONCOLOGY for ASSOCIATION FOR CLINICAL ONCOLOGY
2nd Quarter (Apr 1 - June 30) 2025 · Virginia · House · Senate
Medicare/Medicaid, Health Issues, Tobacco, Budget/Appropriations
View →
Q2
THE KPM GROUP DC LLC for ASTRIA THERAPEUTICS, INC.
2nd Quarter (Apr 1 - June 30) 2025 · Massachusetts · House · Senate · $40,000.00 income
Pharmacy
View →
Q2
THE KPM GROUP DC LLC for INOZYME PHARMA
2nd Quarter (Apr 1 - June 30) 2025 · Massachusetts · House · Senate · $20,000.00 income
Pharmacy
View →
Q2
THE KPM GROUP DC LLC for PRAXIS PRECISION MEDICINES
2nd Quarter (Apr 1 - June 30) 2025 · Massachusetts · House · Senate · $40,000.00 income
Pharmacy
View →
Q2
ORCHARD THERAPEUTICS NORTH AMERICA for ORCHARD THERAPEUTICS NORTH AMERICA
2nd Quarter (Apr 1 - June 30) 2025 · Massachusetts · House · Senate
Health Issues, Medicare/Medicaid
View →
Previous Page 9 of 11 Next

Source: federal Lobbying Disclosure Act filings. A filing's bill references are parsed from its activity descriptions, so a bill page shows the filings that named it.

Report a problem